Want to Avoid an FDA Inspection? Inspect Yourself First
Tags: auditing, defibrillators, FDA, inspections, internal, quality systems, St. Jude Medical, Warning Letters

This post was contributed by FDAImports.com Regulatory Consultant, Walt Brittle
Recently, Dan Starks, CEO of St. Jude Medical, Inc., announced to the media and investors that their Sylmar plant would likely receive a Warning Letter in response to an inspection prompted by St. Jude’s 2010 recall of faulty wires used in defibrillators. The company hoped to inform and reassure investors with the announcement that the Warning Letter was little more than FDA “exercising its role in a very vigorous and robust way.” As predicted, the plant did receive a … READ MORE





The FDA has recently made public and easily